Daily SignalsNeutral
2683 companies scored · 2026-10-15 run in progress: 5118 of ~5380 signals so far · Alpha · vs marketSwitch to Total · 30D 90D
Distribution of the day's forecasts
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
64 companies
Sorted by 90D forecast ↓
| Ticker | Rating | 90D | Δ |
|---|---|---|---|
| AMRXAmneal Pharmaceuticals, Inc. | +0.36% | · | |
| PRAXPraxis Precision Medicines, Inc. | +0.34% | · | |
| ROIVRoivant Sciences Ltd. | +0.31% | · | |
| SGMTSagimet Biosciences Inc. | +0.28% | · | |
| ADXNAddex Therapeutics Ltd. | +0.25% | · | |
| ALNYALNYLAM PHARMACEUTICALS, INC. | +0.25% | ▲ 1 | |
| CYPHCYPHERPUNK TECHNOLOGIES INC. | +0.24% | · | |
| PGENPRECIGEN, INC. | +0.24% | ▼ 2 | |
| PRGOPERRIGO Co plc | +0.24% | · | |
| MISTMilestone Pharmaceuticals Inc. | +0.22% | ▼ 1 | |
| HALOHALOZYME THERAPEUTICS, INC. | +0.21% | ▼ 1 | |
| GMABGENMAB A/S | +0.17% | · | |
| AMRNAMARIN CORP PLC\UK | +0.16% | · | |
| SIGASIGA TECHNOLOGIES INC | +0.16% | · | |
| MOLNMOLECULAR PARTNERS AG | +0.14% | · | |
| AUTLAutolus Therapeutics plc | +0.12% | ▼ 2 | |
| HCMHUTCHMED (China) Ltd | +0.10% | · | |
| KROSKeros Therapeutics, Inc. | +0.10% | ▼ 2 | |
| LXRXLEXICON PHARMACEUTICALS, INC. | +0.07% | ▼ 1 | |
| PTCTPTC THERAPEUTICS, INC. | +0.06% | · | |
| SPRYARS Pharmaceuticals, Inc. | +0.06% | · | |
| ENGNenGene Therapeutics Inc. | +0.04% | ▼ 2 | |
| INSMINSMED Inc | +0.03% | · | |
| ANABANAPTYSBIO, INC | 0.00% | · | |
| QTTBQ32 Bio Inc. | -0.03% | · | |
| BBIOBridgeBio Pharma, Inc. | -0.04% | · | |
| CLLSCellectis S.A. | -0.04% | · | |
| XTLBXTL BIOPHARMACEUTICALS LTD | -0.05% | new | |
| QGENQIAGEN N.V. | -0.07% | ▲ 1 | |
| AGIOAGIOS PHARMACEUTICALS, INC. | -0.11% | · | |
| PRTAPROTHENA CORP PUBLIC LTD CO | -0.12% | · | |
| SANASana Biotechnology, Inc. | -0.12% | · | |
| VTRSViatris Inc | -0.13% | · | |
| COGTCogent Biosciences, Inc. | -0.14% | ▲ 1 | |
| ACBAURORA CANNABIS INC | -0.15% | · | |
| CYRXCryoport, Inc. | -0.16% | ▼ 1 | |
| NRIXNurix Therapeutics, Inc. | -0.18% | · | |
| MRKMerck & Co., Inc. | -0.19% | ▲ 1 | |
| CGENCOMPUGEN LTD | -0.22% | · | |
| FTHFaeth Therapeutics, Inc. | -0.24% | ▼ 2 | |
| GALTGALECTIN THERAPEUTICS INC | -0.26% | · | |
| NWBONORTHWEST BIOTHERAPEUTICS INC | -0.32% | · | |
| SABSSAB Biotherapeutics, Inc. | -0.33% | · | |
| INVAInnoviva, Inc. | -0.41% | ▲ 1 | |
| BMRNBIOMARIN PHARMACEUTICAL INC | -0.45% | ▲ 1 | |
| SMMTSummit Therapeutics Inc. | -0.47% | · | |
| LLYELI LILLY & Co | -0.48% | ▼ 1 | |
| BHCBausch Health Companies Inc. | -0.49% | · | |
| BMYBRISTOL MYERS SQUIBB CO | -0.50% | ▲ 2 | |
| ABBVAbbVie Inc. | -0.51% | ▲ 2 |
By sector
Median 90D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-15) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.